Tens of thousands more women at increased risk of breast cancer could now benefit from a proven risk-reducing drug on the NHS, after it was licensed in a new use to help prevent the disease.

Anastrozole, which has been used for many years as a breast cancer treatment, has today been licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) as a preventive option.

Read more – NHSE (7/11/23)